Hypertension and Lifestyle Modifications: Beyond Controversy

Bhupendra Chaudhary *

Department of Neurosciences, Jaswant Rai Speciality Hospital, Meerut, U.P., India.

Ansh Chaudhary

Department of Medicine, Bharati Vidhyapeeth University, Medical College Pune - Satara Road, Pune-43, Maharashtra, India.

*Author to whom correspondence should be addressed.


Abstract

Traditional approaches to controlling the epidemic of blood pressure-related atherosclerotic cardiovascular disease (ASCVD) in people with hypertension have mostly focused on pharmacological therapy. Nonetheless, nonpharmacologic therapy, commonly known as lifestyle modification, plays an essential and rising role in addition to medication therapy. Specifically, non-pharmacol­ogic therapies can serve as initial therapy in Stage 1 hyperten­sive patients, facilitate medication step down or withdrawal in patients with well-controlled hypertension, prevent hyper­tension in high-risk populations, and reduce blood pressure in normotensive individuals and thereby lower their risk of ASCVD.

It particularly refers to life-style modifications i.e. therapeutic lifestyle changes (TLC) which include reducing dietary sodium, exercise for at least 30 min per day, five days per week; to have Dietary Approach to stop Hypertension (DASH) diet protocol and to achieve a weight loss goal of 4.5 kg or more by non-pharmacological measures such as increased physical activity, reduced salt intake, reduced fat intake, alcohol abstinence, smoking cessation, behavioural changes, yoga, meditation etc.

In fact, when we talk about controlling of hypertension, lifestyle modifications is always the first step of foremost importance.

Keywords: Hypertension, cardiovascular disease, lifestyle, cerebro vascular disease


How to Cite

Chaudhary, Bhupendra, and Ansh Chaudhary. 2022. “Hypertension and Lifestyle Modifications: Beyond Controversy”. Journal of Advances in Medicine and Medical Research 34 (21):337-42. https://doi.org/10.9734/jammr/2022/v34i2131552.

Downloads

Download data is not yet available.